by In2Pharma | Feb 11, 2025 | News
Belgium An update of the Belgian guidance regarding labelling and packaging of medicinal products for human use was published based on the most recent adaptations of the European directives. FAMHP has provided a shortlist of the most important updates: Updated...
by In2Pharma | Aug 23, 2024 | News
Luxembourg La Division de la Pharmacie et des Médicaments de la Direction de la Santé (DPM) has published updated instructions for the distribution of DHPC (version 3.0 – 06/2024) and aRMM (version 4.0 – 06/2024) in Luxembourg. A change in the updated version is...
by In2Pharma | Sep 3, 2021 | News
Europe On 26 July 2021, EMA has launched the IRIS platform, a secure online platform to report marketing status changes and withdrawn product notifications of centrally authorised medicinal products (CAPs) to EMA.The marketing status overview will provide to EMA and...
by In2Pharma | Sep 3, 2021 | News
Europe EMA published a guideline, effective from 1 January 2022, on quality documentation for medicinal products when used with a medical device (first version). The guideline describes the information that should be presented in the Quality part of a MA dossier for a...
